about
"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?Launching PCORnet, a national patient-centered clinical research networkClinical research data warehouse governance for distributed research networks in the USA: a systematic review of the literatureToward a science of learning systems: a research agenda for the high-functioning Learning Health SystemPotential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.Active influenza vaccine safety surveillance: potential within a healthcare claims environment.Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance.Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual.Drug safety data mining with a tree-based scan statistic.Data quality assessment for comparative effectiveness research in distributed data networks.Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel.Four health data networks illustrate the potential for a shared national multipurpose big-data network.Orphan therapies: making best use of postmarket data.The next frontier: Fostering innovation by improving health data access and utilizationDistributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care.Query Health: standards-based, cross-platform population health surveillance.Comparative-effectiveness research in distributed health data networks.Design considerations, architecture, and use of the Mini-Sentinel distributed data system.A survey of informatics platforms that enable distributed comparative effectiveness research using multi-institutional heterogenous clinical data.MR volumetry of brain and CSF in fetuses referred for ventriculomegalyUse of antidepressant medications during pregnancy: a multisite study.Early detection of adverse drug events within population-based health networks: application of sequential testing methods.A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations.Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer.Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection.Adaptive licensing: taking the next step in the evolution of drug approval.Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.Medical product safety surveillance: how many databases to use?Identifying health outcomes in healthcare databases.Evidence generation from healthcare databases: recommendations for managing change.The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality.Confounding adjustment in comparative effectiveness research conducted within distributed research networks.Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilators.Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.Developing the Sentinel System--a national resource for evidence development.Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.Impact of exposure accrual on sequential postmarket evaluations: a simulation study.The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
P50
Q28595570-B71A5906-E020-45EC-945C-1F9536369899Q28656423-DE9F7675-9DDA-4ED4-A0E2-97844A75E66CQ28656433-24348194-71A5-4B68-A144-615B033D8F76Q30303062-E2188176-AD2A-41DC-91D5-774F52513C7CQ30371779-F71449C8-90B3-4A65-B148-9999BB262013Q30381137-26E1A836-509F-4F1B-B36D-7E107B2B1BEDQ30423251-6A851150-EB34-40A7-807F-F51384A8DE89Q30588232-781693A9-D82A-475D-BDD0-46EBD7C8B442Q30604219-C6202396-03CD-4FDE-AE01-8F62DCC97205Q30651018-4281E315-DCDE-447F-BF89-C7FE2EF9CCFCQ30787929-A81BAE3F-E1C8-40AB-95E2-AA88A378D9A5Q30835685-1B8956A7-47E5-4053-B20B-552AD25354FDQ30836776-06F2F476-59BA-4FC6-ABB4-1E18E07E9327Q30984482-8AE76BE1-9B04-4DFA-9ADC-C0EC1DC6FB1AQ33579022-053D1545-C13C-4B77-8D1F-A007D72AE10BQ33832876-3981BE23-A0F9-4371-AA97-542843B6D497Q34059351-07DC194C-72A4-418A-90E0-2FE560ADA15AQ34133833-1C6A373C-1F66-46BC-8DB8-84785311CCAFQ34301749-9F6EC61D-70A1-4D11-9935-A3E87BC3B08EQ36016361-6DF3F5F7-C1C0-4B47-BC6E-D06F64DE2F8EQ36955493-451B929C-BB72-4E6E-BB56-6AB044ED0522Q36979056-7D9FC9A4-8090-4ADC-8CBD-33ECAA7A0ABDQ37310355-4FCFEBCD-F4BE-4FE6-B581-24ECA8872B2BQ37370048-AD8BAB4B-91FA-40A4-B6F9-60A86B6B085CQ37374498-08D92D24-FBF8-41AB-981E-AF788539B6DAQ37627403-AAA075B3-E9D8-4ACD-8028-1415FB2E8FA5Q37984169-52128E12-400F-4716-A1CE-4915D4E1707AQ38027120-BFE01B3C-9DF0-4109-A34B-00B8F12220ADQ38425381-BF14B638-9564-49A5-B5E0-6FE452580897Q38568486-484FC21A-D691-42E2-8821-4BF865B6308AQ38835438-F36A0749-860E-4374-B5F2-A60CF7C3EFAAQ39078983-38B81E4A-531C-4B2C-867E-9DED15729594Q42602901-8CEAA257-8FD1-4C8C-BE97-B0574363D821Q43191434-9BF23547-F48A-4CB8-BE28-EAE9B2AF75D2Q44053790-CC4C6808-7CB4-4E9E-933D-B19929AD2022Q44120843-0D3BB2E7-891D-4087-A92D-A6EF5B7B14EBQ44475855-68E79A52-F800-400C-B17C-DEE32889CDD1Q45733534-69972EAF-C323-48A9-BBDB-F8D3A7CD5791Q46362415-86323602-78BC-4AA7-AFA9-8502ED2AFCC5Q46657583-110CD8E7-CECA-49B7-837C-B4035437EA24
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jeffrey Brown
@ast
Jeffrey Brown
@en
Jeffrey Brown
@es
Jeffrey Brown
@nl
Jeffrey Brown
@sl
type
label
Jeffrey Brown
@ast
Jeffrey Brown
@en
Jeffrey Brown
@es
Jeffrey Brown
@nl
Jeffrey Brown
@sl
prefLabel
Jeffrey Brown
@ast
Jeffrey Brown
@en
Jeffrey Brown
@es
Jeffrey Brown
@nl
Jeffrey Brown
@sl
P106
P1153
55757004900
P21
P31
P496
0000-0002-9340-7189